Introduction
Are amyloids, like amorphous aggregates, principally stabilized by hydrophobic interactions? The mechanism Virtually all denatured proteins have a strong propensity of propagation of infectious prion diseases and its relato form amorphous aggregates. This aggregation is tionship to that of noninfectious amyloidoses is also largely driven by the association of hydrophobic regions poorly understood (Harper and Lansbury, 1997 ; Prusiner that are normally buried in the native structure (for reet al., 1998) . For example, what is the nature of the rateview, see Jaenicke and Seckler, 1997) . In contrast to limiting step in de novo formation of amyloids, and how these more frequent disordered aggregates, some prodo preformed fibrils accelerate this process? Lastly, our teins form ordered aggregates called amyloid fibrils.
understanding of the role of cellular factors, such as Amyloidogenic proteins show no obvious sequence simmolecular chaperones, in promoting formation of amyilarity, nor do their native folds resemble one another.
loids is incomplete (Chernoff et al., 1995;  Kaneko et Yet despite this diversity amyloid fibrils appear to share al., 1997). In particular, do in vitro conversion reactions a similar architecture. using purified proteins accurately reproduce the propaAmyloid fibrils are cross ␤-sheet structures in which gation of disease or infection in vivo? the individual ␤ strands run perpendicular to the long
The prion-like phenomenon [PSI ϩ ] of the yeast Sacaxis of the fibril, whereas the faces of the ␤ sheets extend charomyces cerevisiae provides a powerful model sysparallel to it (Lansbury et al., 1995; Sunde and Blake, tem to address these questions. [PSI ϩ ] is a non-Mende-1997). These fibrils are roughly 100 Å in diameter and are lian trait that causes suppression of nonsense mutations typically composed of 4-6 interwoven protofilaments. (Cox et al., 1988) . This nonsense suppression is thought to result from the conversion of the translation terminaRecent X-ray diffraction studies suggest that the ␤ tion factor Sup35p from a soluble and functional state sheets composing the individual protofilaments are into insoluble and inactive amyloid fibrils (Wickner et al., twisted , resulting in a helical conformation propagating 1995; see Lindquist, 1997) . [ PSI ϩ ] appears to propagate along the amyloid axis (Sunde et al., 1997; see, however, by a prion-like mechanism in which the amyloid form of Lazo and Downing, 1998) . The ordered structure of amySup35p promotes the conversion of newly made soluble loids allows them to bind the dye Congo red at regular Sup35p to insoluble fibrils. The increased nonsense suppression caused by the [PSI ϩ ] factor can be readily monitored by using a strain carrying a marker gene with a ‡ To whom correspondence should be addressed. § These authors contributed equally to this work. nonsense mutation. Thus, the [PSI ϩ ] phenomenon allows one to assess the microscopic aggregation state of the function. The C-terminal domain, referred to as EF because of its homology to elongation factors, encodes a Sup35p protein in vivo by examining the macroscopic properties of a yeast colony. translation termination activity (Stansfield et al., 1995) . Expression of this domain without a PrD provides a Here, we use the [PSI ϩ ] system to define the sequence requirements for efficient formation and prion-like proppool of soluble, active EF domain, resulting in a loss of nonsense suppression even in cells containing wild-type agation of Sup35p amyloids in vivo. In addition, using an in vitro conversion reaction (Glover et al., 1997; King (WT) Sup35p aggregates (Ter-Avanesyan et al., 1993 Figure 1B ). To Sup35p is composed of three domains (Ter-Avanesyan et al., 1993) (Figure 1A ). The N-terminal prion determintrack the suppression phenotype, a [PSI ϩ ] strain harboring a nonsense mutation in the ADE1 gene was used ing domain (PrD) is necessary and sufficient for propagation of aggregates. Deletion of this domain allows (Chernoff et al., 1995) . In yeast retaining their nonsense suppression phenotype, functional Ade1p is produced Sup35p to remain soluble even in [PSI ϩ ] cells (Paushkin et al., 1996) . Conversely, fusion of the PrD to GFP conresulting in white colonies on complete medium (YPD) and an ability to grow on medium lacking adenine (SDfers aggregation of the fusion protein in a [PSI ϩ ]-dependent manner (Patino et al., 1996) . The middle domain ADE). However, in either [psi Ϫ ] or antisuppressed yeast, Ade1p is truncated and nonfunctional, resulting in red (M) of Sup35p is a highly charged region of unknown (1) PN9K, Q24R; (2) PQ10R, Q91L; (3) PQ15R, Q33R; (4) PQ24R, N26D, where the mutant is denoted by the first letter of the phenotype (A or P) followed by the amino acid changes. For double mutants, changes outside of residues 8-24 are not reported when they do not affect the phenotype. (B) Average glutamine/asparagine content of the PrD as function of residue number. The color indicates the percent of glutamine and asparagine residues in a window spanning nine amino acids (scale is indicated on the right). The black bar above the graph marks the location of the isolated PrD mutations.
colonies on YPD and failure to grow on SD-ADE. The PrD expression of PNM mutants ranged from ‫%05-%1ف‬ and generally increased with expression time. We screened was uniformly mutagenized using PCR under conditions that favored single nucleotide changes. A library of ‫000,51ف‬ colonies for ASU phenotypes and ‫000,03ف‬ colonies for PNM phenotypes. In this pool, we estimate sup35 genes with mutagenized PrDs was episomally expressed on a URA3-marked plasmid in a strain that that every point mutant is represented 5-to 10-fold. In total, 28 ASU and 13 PNM mutants were sequenced. contains chromosomally encoded WT Sup35p.
Yeast expressing compromised PrDs were readily The observed redundancy in recovered alleles is in good agreement with this estimated overrepresentation (Figidentified because they formed red/white sectored colonies on YPD ( Figure 1C ). White sectors result from yeast ure 2A). The individual mutations are denoted by the first letter of the phenotype (A or P) followed by the that have lost the plasmid expressing mutant Sup35p but have retained WT aggregates. Conversely, red secamino acid changes. Unexpectedly, all ASU and PNM mutants contained tors result from either an ASU phenotype caused by the presence of the mutant Sup35p or conversion to [psi Ϫ ] changes in a short region at the extreme N terminus of the PrD between residues 8 and 24 ( Figure 2A) . The (i.e., permanent loss of all Sup35p aggregates). The ASU phenotype was confirmed by the lack of functional failure to identify mutations outside of this region was not due to lack of diversity in the original mutant pool, Ade1p under growth conditions that require retention of the mutant Sup35p plasmid (i.e., inability to grow on as a number of mutations that did not cause the ASU phenotype were found throughout the PrD. Nor was it SD-ADE, -URA, Figure 1D ). In contrast, the nonsense suppression phenotype returned following plasmid loss because the residues outside this region were unnecessary for PrD function: deletion of residues 53-124 of the (i.e., growth on SD-ADE medium). The ASU mutants were then examined for their ability to cause permanent PrD resulted in an ASU phenotype (data not shown), and a previously described chromosomal PNM mutant conversion to a [psi Ϫ ] state. Such "curing" alleles are referred to as Psi No More (PNM) mutants (Doel et al., maps outside this region (Doel et al., 1994) . Rather, it appears that point mutations outside this region did not 1994). Cured yeast were identified by the presence of red colonies on 5-FOA medium, which selects for yeast result in a sufficiently robust ASU phenotype to pass our screens. Although the entire PrD has a high Gln/Asn that have lost the plasmid expressing the mutant Sup35p. The fraction of cured cells caused by transient content, the subdomain identified by our mutagenesis and charged Arg side chain is likely to be particularily disruptive to protein-protein interactions. Gly or Asn to CUP1 promoter. Use of an inducible promoter minimizes Arg mutations are not observed, however, because they secondary effects that prolonged expression of mutants would require two nucleotide changes.
might have on the solubility of the WT Sup35p. In contrast to WT PrD-GFP, which had uniformly punctate pat-ASU and PNM Mutants Show Diminished terns in [PSI ϩ ] cells, each mutant led to a mixed populaAbility to Be Recruited into WT Sup35p tion of fluorescent patterns: in individual cells, the fusion Aggregates In Vivo proteins either appeared entirely soluble ( Figure 3C ), in The screen for ASU and PNM mutants was based on discrete foci ( Figure 3D ), or more commonly in both the hypothesis that the antisuppression phenotypes re-( Figure 3E ). sulted from a decreased ability of mutant PrDs to be We next examined the aggregation state of the mutant recruited into WT Sup35p aggregates. We tested this PrDs using a centrifugation assay that made it possible using a GFP-based assay described by Lindquist and to determine the solubility of full-length Sup35p protein coworkers (Patino et al., 1996) . WT PrD-GFP converts expressed from its natural promoter (Patino et al., 1996 ; from a diffuse fluorescence pattern in [psi Ϫ ] cells (Figure Paushkin et al., 1996) . In [PSI ϩ ] cells, Sup35p is in aggre-3A) to a punctate pattern in [PSI ϩ ] ( Figure 3B ), making gates that are efficiently separated from soluble protein it possible to monitor the aggregation state of PrD fusion fractions by centrifugation. In contrast, Sup35p in [psi Ϫ ] protein in vivo. Each of the ASU and PNM mutants was cells remains predominately soluble following centrifugation ( Figure 4A , lanes 1-4). To distinguish mutant fused to GFP and put under control of the inducible Sup35p from chromosomally encoded WT protein, the mutant proteins were tagged with the HA antigen. Following centrifugation, levels of soluble and aggregated proteins were examined by Western blot analysis. We found that 9 of the 11 ASU and PNM mutants showed significant increases in soluble protein in [PSI ϩ ] cells (Figures 4A and 4B) . As might be expected from its comparatively weak ASU phenotype, the tagged version of AN8D showed little, if any, increase in soluble protein ( Figure 4A , lanes 5 and 6). AQ14R was atypical, having a strong phenotype, yet little soluble protein and decreased protein levels ( Figure 4A , lanes 7 and 8). We also examined whether expression of the ASU and PNM mutants led to solubilization of WT Sup35p in [PSI ϩ ] yeast by coexpressing HA-tagged WT Sup35p and untagged mutant proteins. Though most ASU mutants did not result in an increase in soluble WT Sup35p, expression of AS17R led to significant solubilization of WT protein ( Figure 4C , lanes 3 and 4). The PNM mutants generally caused a modest increase in soluble WT protein with the strongest effect resulting from expression of PQ24R ( Figure 4C , lanes 5 and 6).
WT Sup35 PrD Rapidly Forms Amyloids In Vitro in a Reaction that Has Both Concentration-Dependent and -Independent Phases
Recently, three groups demonstrated that the PrD domain from Sup35p can form self-propagating aggregates in vitro (Glover et al., 1997; King et al., 1997; Paushkin et al., 1997) , facilitating greatly detailed studies of the mechanism of fibril formation. Although in all of these To initiate conversion, concentrated protein in urea was diluted at that was eliminated by the addition of preformed fibrils, least 100-fold into buffer C and subjected to continuous slow rotathere were dramatic differences in the time scale of tion. At the indicated times, the extent of fibril formation was assayed conversion. In particular, Ter-Avanesyan and coworkers by Congo red (CR) binding. Each time curve was performed at least (Paushkin et al., 1997) observed that in cell-free extracts three times, unless noted otherwise. Errors larger than the size of symbols are indicated by bars. undergoing a constant slow rotation, a protein con-(A) Kinetics of conversion of 2.5 M WT PrD-M in absence (square) taining the PrD and M domains (PrDϪM) was recruited and presence of 0.7% (wt/wt) (triangle) and 3% (wt/wt) (circle) preinto preformed aggregates within 2 hr. In contrast, Lindformed WT fibril. The kinetics of WT seeded with 3% (wt/wt) fibril quist and coworkers found that pure PrD-M formed amywere done in duplicate.
loids slowly: spontaneous conversion took days, and fibrils during long incubation times.
These difficulties could be minimized by slowly rotating the samples during the incubation. Rotation also dimensions and general features to those seen by EM (Glover et al., 1997; King et al., 1997) , this analysis recaused a dramatic increase in the conversion kinetics, as detected by Congo red binding, with seeded reacvealed several novel features. For example, we saw fibrils containing a prominent ‫01ف‬ nm ridge along the tions going to completion in as little as 45 min and unseeded reactions within 180 min ( Figure 5A ). As filament axis as well as branching fibrils and fibrils emanating from globular structures ( Figure 5B ). Branching judged by gel filtration, all of the monomeric starting material appears to have converted to higher order fibrils were also recently observed in AFM analysis of ␤-amyloid protein filaments (Harper et al., 1997b ) and oligomeric forms. We also observed structural changes on this time scale, such as increased ␤Ϫsheet content could be important for creating new fibrils during amyloid propagation. by circular dichroism (data not shown). Finally, EM and AFM analyses directly confirmed that the conversion
The rapid and reproducible kinetics of conversion allowed us to perform quantitative analyses of fibril formaresults in fibril formation ( Figure 5B and data not shown). Although amyloids observed by AFM were similar in tion. The conversion kinetics can be characterized by two terms: a lag time (T0), the time prior to the increase 1993)? Because the seed is oligomeric, the nucleation model predicts that the lag time will show a strong conin Congo red binding, and a conversion time (T c ), the time between initiation of conversion and its completion. centration dependence that approaches zero at high concentrations. We found that within a range of 1.25-6 At 2.5 M, PrD-M has a lag time of 114 Ϯ 4 min and a conversion time of 53 Ϯ 12 min ( Figure 5A ). To eliminate M, increasing PrD-M concentration did lead to a modest (‫-2ف‬fold) decrease in lag time ( Figure 5C ). Further contaminating preformed fibrils, urea-denatured PrD-M (30 kDa) was passed through a 100 kDa filter prior to increases in PrD-M concentration, however, did not lead to a further decrease of T 0 to below 65 min. Thus, at initiation of conversion. This filtration step appeared to be sufficient, as passage through a 50 kDa filter immediconcentrations above 6 M, the rate-limiting step in conversion is unaffected by protein concentration. Imately after dilution from denaturant did not affect the conversion kinetics (data not shown). Addition of inportantly, the molar fraction of Congo red bound also did not change significantly over the observed concencreasing amounts of preformed fibrils accelerated conversion by decreasing T0 without significantly changing tration range (1.25-12 M). Tc. For example, 0.7% (wt/wt) fibrils shortened the T0 to 24 Ϯ 1 min, and 3% (wt/wt) fibrils eliminated the lag Purified Mutant ASU Proteins Show Decreased Rates of Amyloid Formation In Vitro time completely ( Figure 5A ).
Using the in vitro assay, we probed the nature of We next examined the kinetics of de novo amyloid formation for the ASU mutants. A representative converthe rate-limiting step responsible for the lag phase. In particular, is this lag due to the cooperative formation sion curve of an ASU mutant (AQ15R) reveals a marked decrease in conversion kinetics compared to WT PrD-M of an ordered oligomeric nucleus as suggested by the nucleation-polymerization model (Jarrett and Lansbury, ( Figure 6A ). As with the other mutants, the slow rate of fibril formation of AQ15R was predominantly attributable GRV[polyQϩGly] was comparable to GRV [ϪGly] and GRV[ϩGly], respectively, indicating that replacement of to an increase in lag time (T0 ϭ 260 Ϯ 20 min vs. 114 Ϯ 4 min for WT) rather than a change in T c . A summary of the N-terminal residues not identified by mutagenesis had little effect on function of the PrD (Figure 7 and data T 0 of all the mutants is shown in Figure 6B . Significantly, the mutants that showed the lowest solubility in vivo not shown). Intriguingly, GRV(ϩGly) retained its ability to form de novo aggregates, as even at early expression (AN8D and AQ14R) had T 0 values comparable to that of WT protein, whereas the stronger mutants (AS17R, times a small fraction ‫)%1ف(‬ of the [psi Ϫ ] cells showed a punctate fluorescence pattern. At longer incubation AQ15R, and AG20D) showed significantly larger T 0 values.
times, this fraction increased to ‫.%52ف‬ These aggregates are likely to represent, at least in part, genuine To simulate amyloid propagation in vivo, we examined the ability of preformed WT PrD-M fibrils to promote the conversion events, as overexpression of either GRV-GFP fusion in [psi Ϫ ] cells resulted in a enhanced rate of conversion of purified ASU mutant proteins. For 4 of the 6 ASU mutants, addition of WT fibrils did accelerate conversion to [PSI ϩ ] state. Taken together, these observations indicate that even after replacement of the N-terthe conversion kinetics. However, the rate of seeded conversion was significantly slower for all of the ASU minal Gln/Asn region with a polyGln stretch, the PrD retained its ability both to form new aggregates and to mutants than for WT ( Figure 6B ). For example, in the presence of 0.7% (wt/wt) WT fibrils, the T 0 of AQ15R be recruited into existing aggregates. was 83 Ϯ 5 min as compared to 24 Ϯ 1 min for WT. Interestingly, for two of the mutants with the strongest Discussion in vivo phenotype, AS17R and AQ22R, addition of WT fibrils did not increase the rate of amyloid formation, Even though the association of amyloid fibrils with diseven though AQ22R showed only a modest defect in de eases has been appreciated for several decades, little novo fibril formation. Intringuingly, we also found that is known about what makes a protein amyloidogenic. AS17R mutant fibrils fail to seed the conversion of WT The cytoplasmically inherited [PSI ϩ ] factor of yeast proSup35p ( Figure 6C) . vides a powerful system for studying amyloid formation in vivo and in vitro. Here, we have exploited the PSI phenomenon to identify point mutations in the prion-
The N-Terminal Region of the PrD Identified by Mutagenesis Can Be Functionally
determining domain (PrD) of Sup35p that are defective in amyloid formation and propagation. This work differs Replaced with PolyGln Gln and Asn residues are chemically similar, differing fundamentally from previous genetic studies of mammalian amyloid disorders that have relied on identification solely by a single carbon atom separating the carboxyamide group from the backbone. Although the Ser side of naturally occurring mutations which accelerate disease. Such mutations typically increase the propensity chain does not have a hydrogen bond acceptor like a carboxyamide side chain, it is a polar group with a to form amyloids by destabilizing the native state and thus do not report directly on the requirements for amyhydrogen bond donor. To test the functional equivalence of these side chains, we made a series of glutamine loid formation (Kelly et al., 1997; Wetzel, 1997) . The mutants that we have identified allowed us both to replacement variants (GRV) of the Sup35p PrD ( Figure  7 ). In the first set of variants, termed GRV(ϩGly) and define the sequence requirements for Sup35p amyloid formation in vivo and to test the relevance of in vitro GRV(ϪGly), all of the residues in the N-terminal region of the PrD that were identified by mutagenesis, either conversion reactions. Two classes of mutants that lead to increased levels of soluble protein were identified: including or not including the single Gly, respectively, were replaced with Gln. A second set of variants, termed the first (ASU) inhibited incorporation into aggregates without irreversibly preventing propagation of WT amy-GRV(polyQϩGly) and GRV(polyQ-Gly) were made in which all of the residues (amino acids 8-24) in the loids, and the second (PNM) resulted in curing of the [PSI ϩ ] state in addition to its ASU phenotype. In vitro N-terminal region, either including or not including the single Gly, were replaced with Gln. These domains were conversion reactions using pure ASU-PrD proteins indicate that the increased solubility of these mutants is fused to GFP and put under the control of the CUP1 promoter.
caused directly by a defect in recruitment of soluble protein by WT prion-like amyloids. We are currently inWe examined the aggregation state of the GRV-GFP fusion proteins in [ Our studies reveal a critical role for Gln and Asn residues in stabilization of the amyloid state. First, all of the GRV(-Gly)-GFP showed punctate fluorescence even at early points in the induction (3 hr), whereas only diffuse mutations cluster to the most Gln/Asn-rich region of the Sup35p PrD. Second, all of the mutations were found staining was observed in [psi Ϫ ] cells (Figure 7 ). For GRV(ϩGly), at early times the fluorescent pattern in in Gln or Asn residues, with the exception of a single Ser and a single Gly. Finally, when present in the context [PSI ϩ ] cells appeared diffuse in a significant fraction of the cells. At later times, however, a uniformly punctate of full-length Sup35p, this region can be replaced by a polyGln tract while retaining its ability both to form de pattern was observed. This indicates that GRV(ϩGly)-GFP was also capable of being recruited in WT aggrenovo amyloids and to be incorporated into preexisting WT amyloids. These observations argue for the funcgates although with decreased efficiency compared to GRV(-Gly)-GFP. The behavior of the GRV[polyQ-Gly] and tional equivalence of the various polar residues (Gln, Asn, and Ser) in this critical region of the Sup35p PrD. A appears to propagate by a prion-like mechanism (Wickner, 1994) . The protein responsible for the [URE3] state, possible explanation for the stabilization of the amyloid state by Gln/Asn residues was suggested by Perutz and Ure2p, is extremely rich in Asn as well as other polar residues. Furthermore, Ure2p has been reported to form coworkers, who pointed out that in ␤ sheets carboxyamide side chains could form a "polar zipper" involving filaments in vitro (King et al., 1997) . Perhaps most interestingly, a number of neurodegenerative diseases have a network of side chain-main chain hydrogen bonds (Stott et al., 1995) .
recently been found to result from expansion of polyGln repeats that leads to intracellular aggregates in vivo and It is likely that Gln-and Asn-rich domains play an important role in stabilizing a significant subset of amyamyloids in vitro (see below). loid phenomena. The putative PrD region of the Sup35p homolog of Pichia pinus is rich in Asn and Gln, despite
Implications for the Prion Hypothesis
The prion hypothesis argues that a protein alone can act the lack of linear sequence homology with the S. cerevisiae gene (Kushnirov et al., 1990) . Even more striking as an infectious agent, leading to a permanent change in the phenotype of the infected organism (Prusiner et al., is the recently sequenced SUP35 gene from Candida albicans, which contains ‫55ف‬ Gln residues in its putative 1998). This infectivity is thought to result from an altered conformation that both causes the phenotypic change PrD domain, including long stretches of pure Gln repeats near the N terminus. These observations suggest that and promotes conversion of new protein, thereby allowing self-replication. Studies on the mammalian prion protein the amino acid composition of a protein, as much as its exact primary sequence, determines its amyloidogeniPrP, the yeast prion Sup35p, and nonprion amyloids have reproduced self-propagating conformational changes in city. Another epigenetic factor in yeast, [URE3], also vitro (Glover et al., 1997; Harper and Lansbury, 1997;  For example, the molecular chaperone HSP104 is required for maintenance of the [PSI ϩ ] state; paradoxiKing et al., 1997; Paushkin et al., 1997) . Connecting cally, HSP104 also causes loss of [PSI ϩ ] when overexthese conformational changes to the phenotypic change, pressed (Chernoff et al., 1995) . We find that the kinetics however, has proven more elusive. Here, we show that of conversion are enhanced greatly by the addition of pure PrD can propagate amyloids on a physiological a slow rotation step. Similar enhancement in the kinetics time scale in vitro. Moreover, we used a series of point of polymerization is observed when hemoglobin S is mutants that lead to a loss of the prion-associated phesubjected to rotation forces (Briehl, 1980) . Given that in notype to test the relevance of the in vitro conversion the absence of such forces, conversion of Sup35p in reaction. These mutants cause solubilization of protein vitro is far slower than the doubling time of yeast, it is in vivo and decreased rates of de novo amyloid formaan attractive hypothesis that in a growing cell amyloid tion and recruitment into preformed fibrils in vitro. These fibrils undergo continuous disrupton. As noted by Terobservations provide perhaps the most compelling data Avanesyan and coworkers, HSP104 might contribute to to date linking an in vitro conversion reaction to the such an effect, as it has been shown to break up other phenotypic change effected by a prion, thus providing protein aggregates (Paushkin et al., 1996 ; see, however, strong support for the prion hypothesis. Patino et al., 1996) . Using the in vitro assay, we can The studies also furnish insights into the mechanism quantitatively assess the ability of HSP104 or other celluby which the Sup35p prion propagates its altered conlar components to increase the number of polymerizing formation. In vitro characterizations of the kinetics of ends in an amyloid fibril sample. amyloid formation from purified amyloidogenic proteins A molecular chaperone, termed protein X, has also or peptides have suggested that conversion is a nuclebeen implicated in propagation of the prion form of the ation-dependent process (Jarrett and Lansbury, 1993;  mammalian PrP protein (Kaneko et al., 1997) . The idenHarper and Lansbury, 1997). In such processes, the lag tity of protein X is unknown, but its existence has been phase results from the thermodynamically unfavorable inferred by the behavior of a number of dominant-negaformation of competent nuclei and is followed by a contive forms of PrP. Our dominant-negative Sup35p alleles version phase in which the transition from monomer to could also result from altered recognition by a molecular fibril occurs in a rapid, cooperative fashion. The nuclechaperone such a HSP104. Alternatively, our Sup35p ation-polymerization model makes several predictions mutants might form heteropolymers with WT protein (Jarrett and Lansbury, 1993 ) that distinguish it from other that fail to effectively promote conversion of either WT conversion mechanisms (e.g., the template conversion or mutant protein. Consistent with this proposal, GFP model in which the catalyst acts by promoting a rateanalysis reveals that the mutants can be recruited into limiting conformational change [Prusiner and al, 1998 ]).
WT aggregates in vivo. Moreover, in vitro WT and AS17R First, there is a critical monomer concentration below amyloids are mutually defective in seeding each other's which no conversion occurs. Second, the length of the conversion. lag time is highly dependent on the protein concentration. Finally, the lag phase will approach zero at infinite Implications for the Mechanism of CAG concentration, and as this limit is approached, addition Repeat-Mediated Pathogenesis: PolyGln of seed no longer accelerates fiber formation.
Diseases as Intracellular Prions? Here, we tested critically the nucleation-polymeriza-A number of inherited neurodegenerative diseases retion model by examining the kinetics of de novo amyloid sult from expansion of the CAG nucleotide triplet leading formation of Sup35p. We find that within a range of to the insertion of a polyGln tract at the protein level. 1.25-12 M the conversion of monomer appears to go to Concurrent with our studies, polyGln insertions were completion. Thus, the critical concentration, if it exists, is shown to lead to formation of amyloid fibrils in vitro and well below micromolar as compared to 10-40 M for in vivo (e.g., Paulson et al., 1997; Scherzinger et al., ␤-amyloid peptide (Harper and Lansbury, 1997) . We also 1997; see, however, Kahlem et al., 1998) . This polyGlnfind that the rate of amyloid formation shows only modmediated aggregation appears to be intimately associest concentration dependence. In particular, between ated with pathogenesis. 1.25 and 6 M the rate of spontaneous conversion is Our functional analysis of Sup35p amyloid formation approximately first order. At concentrations between 6 raises the interesting possibility that [PSI ϩ ] and polyGlnand 12 M, the lag time has a constant value of ‫56ف‬ min. mediated pathogenesis are related phenomena involvYet this lag phase is completely eliminated by addition of ing intracellular prion-like propagation of amyloid fibrils as little as 3% (wt/wt) preformed aggregate. It remains stabilized by a polar network of carboxyamide side possible that at extremely low concentrations, the kinetchains. There are, however, important differences beics of conversion would be adequately described by tween the aggregation of Sup35p-and polyGln-medithe nucleation polymerization model. However, we find ated amyloid formation. Notably, while the total number dramatic catalysis of fibril formation even at concentraof Gln/Asn residues in Sup35p is comparable to the tions where oligomerization is not rate limiting. These number found in the pathogenic repeat disorders, the data argue that fibrils accelerate the conversion of Gln/Asn tracts in Sup35p are not continuous. There is Sup35p by promoting a conformational change (e.g., also currently no direct evidence to address whether conversion of profibrils to fibrils [Harper et al, 1997a]) polyGln amyloids facilitate their own conversion during rather than solely by providing a multimeric nucleus.
pathogenesis. A prediction of the self-replicating amyAlthough pure Sup35p PrD-M forms amyloids rapidly loid model is that a cell will undergo a stochastic converin vitro, a variety of cellular factors are likely to play an sion event, after which newly made protein will be recruited into amyloid fibrils. Consistent with this, we important role in propagation of the Sup35p prion state. Chernoff et al., 1995) . All nucleic acid and yeast manipulations were mM MgCl2, 1 mM EDTA, 5% Glycerol, 1 mM PMSF, 2 g/ml pepstatin performed according to standard laboratory protocols (Sherman, and leupeptin, and 100 g/ml ribonuclease A). Cell pellets were 1991; Ausubel et al., 1995) . PCR primers were as follows: P1, resuspended in approximately 2 vol of buffer A, 2 vol of glass beads GGCCCCCCTCGAGTGAGAGAACCGTTAAATTCCC; P2, CC CCG G were added, and cells were disrupted by vortexing for 3 min at 4ЊC. ATCCTGCTAGTGGGCAGATATAGAT; P3, GGGAGGCTCGAGCTTC Centrifugation was performed as described (Patino et al., 1996) with AACGATTTCTATGATTC; P4, GGGGGATC CTAT G T GAT GAT T GAT minor modifications. The slurries were spun at 8000 g for 3 min at TGATTG; P5, GCGGGATCCACAATGTCGGATTCAAACCA; P6, CCG 4ЊC to pellet unbroken cells and glass beads; the remaining superna-GCCGAATTCAGATCTATCGTTAAC; P7, CCCCCCAGATCTGAATTC tant was spun at 100,000 g for 30 min at 4ЊC. Supernatant was CCATGGATGTTTGGTGGTAAAGATCAC; P8, CCCCCGAGCTCACC removed, and the pellet was resuspended in an equal volume of TTGTTTATGGTATATGGT; P9, GGGGGGGCATATGTCGGATTCAAA cold buffer A. Samples (20 g of total protein) were analyzed by CCAAGGC; P10, CCGGGACGCGTGAATTCTTAATGGTGGTGATG SDS-PAGE and Western blot analysis (Ausubel et al., 1995) using GTGATGGTGATGATGATCGTTAACAACTTCGTCATC-. S. Cerevisthe 16B12 antibody (Babco) and goat anti-mouse IgG-HRP conjuiae Genomic DNA was used as a PCR template (Stratagene).
gate (Bio-Rad).
Plasmid Construction PrD-M Expression and Purification
To facilitate exchange of promoters and protein domains, PCR was Pure PrD-M was prepared largely as described previously (Glover used to introduce restriction sites flanking the promoter, the PrD-M et al., 1997) . Briefly, cell pellets from 1-2 l of growth were lysed in domain, and the EF domain of SUP35, generating a set of inter-30 ml of buffer B (25 mM Tris [pH 7.8], 300 mM NaCl, 6 M urea). changeable cassettes. The promoter cassette was defined by a 5Ј Subsequent to centrifugation at 25,000 g (20 min), the supernatant XhoI site and a 3Ј BamH1 site, the PrD-M cassette by a 5Ј BamH1 was filtered by 0.22 m filter (Millipore) and applied to 20 ml Ni-NTA site and 3Ј BglII and EcoR1 sites, and the EF cassette by a 5Ј EcoR1 agarose (Qiagen) column. The column was washed with 5 column vol site and a 3Ј SacI site. Two promoters were used: the endogenous buffer B and eluted with a pH gradient in same buffer without NaCl. SUP35 promoter (Sp) (P1 and P2) and the CUP1 promoter (Cp) (P3 Pooled fractions were applied to a 30 ml Source 15S column (Pharand P4). PrD-M domains were generated by P5 and P6. The EF macia) equilibrated in 50 mM MES [pH 6.0], 6 M urea and eluted domain was generated using P7 and P8. This domain was exwith 0-400 mM NaCl gradient in the same buffer. Pure PrD-M was changed with GFP where indicated; GFP containing the appropriate concentrated with centricon-10 (Amicon), filtered by microcon-100 sites was derived from pRS316-Pho4-GFP (E. K. O'Shea, personal (Amicon), aliquoted, and stored at Ϫ80ЊC. Protein concentration communication). Epitope tags were inserted between the M and EF was determined by UV absorption at 275 nm. domains, using the 5Ј BglII site and the 3Ј EcoR1 site. All plasmids were derived by ligating the insert between the Xho1/Sac1 sites of the following vectors; pRS316 (low copy CEN/ARS, URA3ϩ), Congo Red Binding Assay Congo red binding assays were carried out largely as described pRS315 (low copy CEN/ARS, LEU2ϩ), and pRS426 (high copy 2 m, URA3ϩ) (Christianson et al., 1992) . Constructs are denoted by previously (Klunk et al., 1989) . Congo red (Sigma) was dissolved in buffer C (5 mM potassium phosphate, 150 mM NaCl), filtered with the plasmid backbone, promoter, PrD allele, and whether the EF or GFP domain is present (Epitope tags are noted between the PrD-M 0.22 m filter (Millipore), and adjusted to 100 mM. To initiate conversion, concentrated PrD-M was diluted at least 100-fold into buffer and EF domains where relevant). For bacterial expression, the appropriate allele of PrD-M was amplified using P9 and P10, which C in 2 ml microcentrifuge tubes at room temperature. The solution was subjected to constant rotation (7.5 rpm) using a RKVS Rotamix introduces a His tag at the C terminus. These products were subcloned into NdeI/EcoRI sites of a T7 expression vector. The se-(ATR). At indicated times, protein was diluted to 2 M in the presence of 10 M Congo red in buffer C. Absorbances at 540 and 477 nm quence of all plasmids was confirmed by dye termination sequencing (Perkin Elmer).
were determined (either by Shimadzu UV160U or Aviv 14DS spectrophotometer). Congo red bound per mole of PrD-M was determined by the formula (A540/25292)-(A477/46306). Quantitative measurement Screen for ASU and PNM Mutants The SUP35 PrD was mutagenized by 30 rounds of PCR amplification of the length of the lag phase (T 0) was performed by fitting the middle of the sigmoidal curves with a straight line and solving the time for with Taq polymerase using the manufacturer's conditions and P1 which the amount of Congo red bound is that of baseline. 
